Existing genetic-linked disparities for vascular disease among minority populations in the U.S., such as hypertension, diabetes, cardiovascular disease, kidney disease, and AD, supports the notion that EDN-1 gene variants may exist, which could result in a predisposition to having long-term high ET-1 levels, particularly in AA males. The gene discussed is EDN1; the disease is cardiovascular disorder.